Exact Sciences, Gastro Health & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

Motus GI named Jeff Hutchison vice president of U.S. sales and commercial operations.

Motus GI released its second quarter 2018 financial results, posting a $4.2 million net loss, or $0.27 per diluted share.

Exact Sciences, the manufacturer of Cologuard, and the Green Bay Packers launched "Crossing the 50," a new campaign to raise money for the Vince Lombardi Cancer Foundation.

Miami-based Gastro Health made a series of leadership appointments as the practice continues to expand.

The FDA awarded Array Biopharma's mutant metastatic colorectal cancer treatment the breakthrough therapy designation.

More articles on gastroenterology:
'U.S. News and World Report' names the top 10 hospitals for GI
Motion filed to limit media contact for gastroenterologist accused of sexual misconduct
ASGE recognizes Chicago gastroenterologist for quality: 4 insights

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months